| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/31/2009 | US20090324712 Methods and compositions related to production of coenzyme q10 |
| 12/31/2009 | US20090324711 Oral Pharmaceutical Composition of Anilinopyrimidine, Preparation and Use Thereof |
| 12/31/2009 | US20090324710 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 12/31/2009 | US20090324709 Liposomal formulations |
| 12/31/2009 | US20090324708 Compound having inhibitory activity on a rho-gtpase cell protein, a process for obtaining the same, pharmaceutical compositions comprising thereof and a method for the treatment of rho-gtpase cell protein-mediated condition |
| 12/31/2009 | US20090324707 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 12/31/2009 | US20090324706 Nanostructures Suitable for Sequestering Cholesterol and Other Molecules |
| 12/31/2009 | US20090324705 Phytonutrient compositions for topical use |
| 12/31/2009 | US20090324704 Phosphate diester amides |
| 12/31/2009 | US20090324703 Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders |
| 12/31/2009 | US20090324702 Novel viral vector |
| 12/31/2009 | US20090324701 Compositions containing (s)-bethanechol and their use in the treatment of insulin resistance, type 2 diabetes, glucose intolerance and related disorders |
| 12/31/2009 | US20090324700 Methods and compositions for the inhibition of cathepsins |
| 12/31/2009 | US20090324699 Antihistamine-and corticosteroid-containing lipsome composition and its use for the manufacture of medicament for treating rhinitis and related disorders |
| 12/31/2009 | US20090324698 Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof |
| 12/31/2009 | US20090324697 Transdermal hormone delivery system: compositions and methods |
| 12/31/2009 | US20090324695 Biocompatible polymer ceramic composite matrices |
| 12/31/2009 | US20090324694 Gastroretentive drug delivery system comprising an extruded hydratable polymer |
| 12/31/2009 | US20090324693 Delivery Product for Topical Compositions |
| 12/31/2009 | US20090324692 Polyurethane Elastomers |
| 12/31/2009 | US20090324690 Transscleral delivery |
| 12/31/2009 | US20090324689 inhibiting the transition from the dry form of age-related macular degeneration to the wet form with rapamycin or analogs such as AP 23841, zotarolimus, tacrolimus, everolimus, pimecrolimus, temsirolimus; implants |
| 12/31/2009 | US20090324688 Transscleral delivery |
| 12/31/2009 | US20090324687 Transscleral delivery |
| 12/31/2009 | US20090324686 mTOR inhibitor effective to treat macular edema; rapamycin or analogs such as AP 23841, zotarolimus, tacrolimus, everolimus, pimecrolimus, temsirolimus; treatment of wet age related macular degeneration |
| 12/31/2009 | US20090324683 Controlled release tissue graft combination biomaterials |
| 12/31/2009 | US20090324682 Medical stent provided with inhibitors of atp synthesis |
| 12/31/2009 | US20090324680 Nanofiber-reinforced composition for application to surgical wounds |
| 12/31/2009 | US20090324679 Medical copolymers |
| 12/31/2009 | US20090324675 Bioocompatible polymer compositions |
| 12/31/2009 | US20090324668 Implant, its uses and methods for making it |
| 12/31/2009 | US20090324664 Spray-on, non-woven fabric system and multilayer topical covering |
| 12/31/2009 | US20090324654 Sunscreen composite particles and porous particles in cosmetic compositions |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/31/2009 | US20090324512 Polypeptide constructs for nasal administration |
| 12/31/2009 | US20090324511 Compounds, Compositions and Methods |
| 12/31/2009 | US20090324510 Drug combinations for the treatment of respiratory tract diseases |
| 12/31/2009 | US20090324508 Broad Spectrum and Skin Friendly Disinfecting Composition |
| 12/31/2009 | US20090324507 RNAi-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions |
| 12/31/2009 | US20090324506 Sprayable skin protectant formulation and method of use |
| 12/31/2009 | US20090324505 Surfactant gas pressurized liquid composition and method and package for delivering |
| 12/31/2009 | US20090320435 Fiber Strand and Implantable Supporting Body Having a Fiber Strand |
| 12/31/2009 | DE102008040042A1 Microparticle, useful in the diagnosis or therapy of e.g. tumors, metabolic diseases, comprises an aggregate from superparamagnetic nanoparticle, where the nanoparticle exists alone or in combination with an active agent, e.g. antibody |
| 12/31/2009 | DE102007001953B4 Mikrostrukturierter Film, Verfahren zu seiner Herstellung und seine Verwendung Microstructured film, process for its preparation and its use |
| 12/30/2009 | WO2009158724A2 Improved injectable delivery of microparticles and compositions therefore |
| 12/30/2009 | WO2009158687A1 Dermal delivery |
| 12/30/2009 | WO2009158678A1 Lipophilic nucleic acid delivery vehicle and methods of use therefor |
| 12/30/2009 | WO2009158668A1 Prodrugs and drug-macromolecule conjugates having controlled drug release rates |
| 12/30/2009 | WO2009158584A1 Dual adhesive technology |
| 12/30/2009 | WO2009158480A2 Stimulation of cartilage formation using reduced pressure treatment |
| 12/30/2009 | WO2009158477A1 Skin patches and sustained-release formulations comprising lofexidine for transdermal and oral delivery |
| 12/30/2009 | WO2009158415A1 Octreotide implant having a release agent |
| 12/30/2009 | WO2009158412A2 Sustained delivery of exenatide and other polypeptides |
| 12/30/2009 | WO2009158387A2 Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption |
| 12/30/2009 | WO2009158368A1 Coated particles containing pharmaceutically active agents |
| 12/30/2009 | WO2009158300A1 Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof |
| 12/30/2009 | WO2009158256A2 Transdermal delivery apparatus and method |
| 12/30/2009 | WO2009158120A2 Stabilized transdermal drug delivery system |
| 12/30/2009 | WO2009157886A1 Antitumoral, antioxidant and immunomodulatory composite agent |
| 12/30/2009 | WO2009157711A2 Gastro-retentive porous tablet and method for preparing same |
| 12/30/2009 | WO2009157586A1 Transdermal patch containing fentanyl or salt thereof |
| 12/30/2009 | WO2009157561A1 Polymer/metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same |
| 12/30/2009 | WO2009157558A1 Agent for regenerating tympanic membrane or external auditory canal |
| 12/30/2009 | WO2009157279A1 Liquid composition comprising cisplatin-coordinating compound |
| 12/30/2009 | WO2009157214A1 Spherical non-crystalline magnesium aluminosilicate |
| 12/30/2009 | WO2009157173A1 Percutaneous absorption enhancer and transdermal preparation using the same |
| 12/30/2009 | WO2009157073A1 Nano-level lactic acid bacterium |
| 12/30/2009 | WO2009156796A1 Pharmaceutical compositions of rosuvastatin calcium |
| 12/30/2009 | WO2009156743A2 Magnetic microbubbles, methods of preparing them and their uses |
| 12/30/2009 | WO2009156706A1 Pulmonary drug delivery with vesicles comprising non-ionic surfactants |
| 12/30/2009 | WO2009156679A1 Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
| 12/30/2009 | WO2009156369A1 Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
| 12/30/2009 | WO2009156180A2 Polymeric delivery systems for active agents |
| 12/30/2009 | WO2009156173A1 Pharmaceutical composition comprising a statin |
| 12/30/2009 | WO2009156160A1 Pharmaceutical compositions comprising a complex of aminocyclohexane derivatives and cyclodextrin |
| 12/30/2009 | WO2009156128A1 Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1 h-pyrrole-3-carboxamide |
| 12/30/2009 | WO2009156014A1 Bitablets comprising compacted polyallylamine polymer and method for the production thereof |
| 12/30/2009 | WO2009155931A1 Acetic acid and a buffer |
| 12/30/2009 | WO2009155777A1 The use and method of the compound of fasudil and the pharmaceutical composition thereof |
| 12/30/2009 | WO2009155757A1 A pharmaceutical composition containing oligosaccharide obtained from morinda root and the procedure thereof |
| 12/30/2009 | WO2009155753A1 The use of inositol derivative or salts thereof in the manufacture of medicaments as glycosidase inhibitors or medicaments for treating diabetes |
| 12/30/2009 | WO2009155711A1 Analysis of lactobacillus acidophilus la-5 signal interference molecules |
| 12/30/2009 | WO2009155689A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections |
| 12/30/2009 | WO2009155626A2 Functionally intact fibrinogen remaining stable during storage |
| 12/30/2009 | WO2009136982A3 Self-injection guide tablet |
| 12/30/2009 | WO2009123732A3 Demulsifiers and methods for use in pharmaceutical applications |
| 12/30/2009 | WO2009107088A3 Method for producing an implantable bone composition |
| 12/30/2009 | WO2009101021A3 Estradiol-containing drug delivery system |
| 12/30/2009 | WO2009094641A3 Topically active steroids for use in interstitial pulmonary fibrosis |
| 12/30/2009 | WO2009088414A3 Oral pharmaceutical dosage forms |
| 12/30/2009 | WO2009072079A3 Polymeric drug carrier for image-guided delivery |
| 12/30/2009 | WO2009069151A3 Controlled release composition |
| 12/30/2009 | WO2009066146A3 Stable solutions of sparingly soluble actives |
| 12/30/2009 | WO2009034541A9 Controlled release pharmaceutical dosage forms of trimetazidine |
| 12/30/2009 | WO2009033131A3 Multi-phasic, nano-structured compositions containing a combination of a fibrate and a statin |
| 12/30/2009 | WO2009023672A3 Abuse resistant drugs, method of use and method of making |
| 12/30/2009 | WO2008124617A3 Rapidly dissolving pharmaceutical compositions comprising pullulan |
| 12/30/2009 | WO2008088922A3 Prevention of hydrogel viscosity loss |
| 12/30/2009 | EP2138192A1 Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent |